Table 4 Baseline parameters in responders and non-responders

From: Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia

  Responders QoL reduction 2 (n=23) Non-responders QoL reduction <2 (n=15) P-value
Gender (M/F) 11/12 10/5 0.254
SCI level (C/T/L) 9/10/4 4/11/0 0.106
DSD type (1/2/3) 9/10/4 5/4/6 0.341
Pdet.Qmax (cm H2O) 40±20.3 41.8±23.52 0.808
PVR (ml) 119.13±102.2 166.47±96.9 0.163
Compliance 25.87±25.3 28.38±26.6 0.771
  1. Abbreviations: DSD, detrusor sphincter dyssynergia; M/F, male to female; Pdet.Qmax, detrusor pressure at maximum ow rate; PVR, post-void residual; SCI, spinal cord injury; QoL, quality of life.